Press "Enter" to skip to content

Researchers at Pancreatic Cancer will get great success, patients will be treated in these treatments

Pancreatic Cancer: The cancer of the pancreas related to cancer, also called pancreatic cancer, has been suggested to treat it in a new research.

In a new research, patients with pancreatic cancer have been told to benefit from the use of PHLPP1 and PKC enzyme levels. From this, researchers can develop new medicines, which will change the balance of both enzymes. This process will help in the treatment of people suffering from pancreatic cancer.

According to the news agency Xinhua, this research has been published in ‘Molecular Cell’ on Wednesday. This research was done by Alexandr Newton and Timothy Buffy of the Department of Pharmacology at the University of California, San Diego.

The new research is based on the team work of 2015, which found that enzyme PKC actually works to prevent pancreatic cancer. In its previous study it was believed that it enhances the growth of the tumor.

Recent research has shown how cells control PKC and detect greater activity of PKC. Newton said, This means that PHLPP 1 decides the amount of PKC in your cells.’ He said, ‘It brings changes in enzyme levels for pancreatic cancer.’

Let us tell you that recently the former Defense Minister of India and Goa Chief Minister Manohar Parrikar died due to pancreatic disease. For a long time his health was witnessing a huge decline, but despite this he continued his duty honestly till the last time. He had drip in his name and in this state many times he was seen working on several projects.

[Total: 0    Average: 0/5]

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *